The Agency for Health Economic Assessment and Dissemination – AHEAD - is a specialized
consulting agency that supports clients in the planning, generation and dissemination of health economic evidence as well as in obtaining market access and reimbursement in Germany.
Health Economic Evidence Assessment
Planning: Determination which health economic assessments are essential for your product from the market launch, the HTA/payer and the KOL/provider perspective.
Generation: Development and application of health economic evaluations and/or models in order to generate the health economic evidence for your product.
Dissemination: Communication of the health economic value messages (based on the health economic assessment results) to decision makers, payers, providers & KOLs.
Market Access and Reimbursement in Germany
Market Access & Reimbursement: Evaluation and implementation of market access strategies and of reimbursement strategies for digital health applications, medical devices and for pharmaceuticals in Germany.
The AHEAD philosophy is to provide high-quality, product-specific and client-need-specific
consulting & research activities that will be delivered on time.
D-74321 Bietigheim-Bissingen, Germany
Phone + 49 (0) 7142 914 1470
Mobile + 49 (0) 1577 194 8125
Please download and save the AHEAD - Capability Presentation and the AHEAD - Capability Presentation including Project Showcases.
Our professional indemnity and general liability are secured by the exali insurance for consulting companies.
We are happy to announce that the AHEAD GmbH has moved its office to the Stuttgart region and the new legal address is: Wilhelm-Leibl-Str. 7, 74321 Bietigheim-Bissingen, Germany. Due to the move the commercial registration has moved to the Registry Court of Stuttgart and the new registry number of the AHEAD GmbH is HRB781989.
Great News: Our joint research article named “Robotic hysterectomy compared with laparoscopic hysterectomy: is it still more costly to perform?” has been Published in the Journal of Robotic Surgery and is available here.
We are happy to announce publication of our joint epidemiologic research named “Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study” in the journal “Orphanet Journal of Rare Diseases”. Due to the support of German key centers and KOLs in the field of aTTP it was possible to develop and conduct a study that was accepted by the G-BA / IQWiG for estimation the aTTP patient population in Germany. Great thanks again to all that have participated to this research! The full text of the article is available here.
Our joint research named “Cost of ownership assessment for a da Vinci robot based on US real-world data” that was developed in cooperation with CAVA Robotics has just been published in the International Journal of Medical Robotics and Computer Assisted Surgery. The full text of the article is available here.